{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:11Z","timestamp":1792788071555,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>INTRODUCTION:<\/jats:title>\n                    <jats:p>Approximately 5% of donated plasma has a green appearance, due to elevated ceruloplasmin levels from increased estrogen. These products are currently discarded based on color alone. However, studies have shown improved trauma outcomes from female donors. In an ex vivo study, we recently noted accelerated and increased clot production with green plasma. The purpose of this study was to assess whether these findings could be confirmed in an in vivo animal model of severe hemorrhage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We utilized a well-established rat model of uncontrolled hemorrhage. Following cannulation and anesthesia, 33 rats underwent midline laparotomy followed by excision of 50% of the middle hepatic lobe to induce hemorrhage. After 60 seconds, GREEN (11 rats), standard FEMALE (11), or MALE plasma (11) were infused at a fixed volume of 5\u00a0mL. Abdominal cavity blood was collected to evaluate blood loss every 15 minutes for 60 minutes. Deaths occurring before experiment termination were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Rats resuscitated with GREEN plasma had improved shock index compared with FEMALE and MALE at 15 (3.7 vs. 6.2 vs. 10.2;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =0.092), 30 (3.8 vs. 8.2 vs. 6.5;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =0.039), and 60 minutes (3.9 vs. 29.9 vs. 7.1;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =0.015). Mean arterial pressures in GREEN plasma-resuscitated rats were higher at 30 (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =0.032) and 60 minutes (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      =0.115). Cumulative percent blood volume lost was lower at each time point in those receiving GREEN plasma. Survival to 60 minutes was 100% among GREEN and FEMALE plasma rats but only 64% among MALE resuscitated ones (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Our study demonstrated that green plasma has improved efficacy for reducing bleeding and restoring hemodynamic stability compared with standard plasma in a rodent model of uncontrolled hemorrhage. Combined with our recent ex vivo data noting equivalent (often superior) hemostatic potential compared with standard units, we recommend reintroducing this often-discarded AABB-approved product back into the plasma donor pool.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ta.0000000000005071","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:03:02Z","timestamp":1781546582000},"page":"784-789","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["An in vivo assessment of green plasma: The potential hemostatic superiority of a currently discarded blood product"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5655-3366","authenticated-orcid":false,"given":"James M.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha C.","family":"Redden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Wei W.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle K.","family":"McNutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Cardenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan A.","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"10","key":"R1-20261023","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/jth.12351","article-title":"Fresh frozen plasma: the most commonly prescribed hemostatic agent","volume":"11","author":"Puetz","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"1","key":"R2-20261023","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1537-2995.2010.02798.x","article-title":"The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children","volume":"51","author":"Stanworth","year":"2011","journal-title":"Transfusion"},{"key":"R3-20261023","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/trf.17360","article-title":"Continued stabilization of blood collections and transfusions in the United States: findings from the 2021 National Blood Collection and Utilization Survey","volume":"63","author":"Free","year":"2023","journal-title":"Transfusion"},{"issue":"6","key":"R4-20261023","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/TA.0000000000000641","article-title":"Massive transfusion policies at trauma centers participating in the American College of Surgeons Trauma Quality Improvement Program","volume":"78","author":"Camazine","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"issue":"8","key":"R5-20261023","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/trf.12223","article-title":"How we manage AB plasma inventory in the blood center and transfusion service","volume":"53","author":"Yazer","year":"2013","journal-title":"Transfusion"},{"issue":"6","key":"R6-20261023","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1537-2995.1985.25686071434.x","article-title":"Diagnostic and pathogenetic considerations in transfusion-related acute lung injury","volume":"25","author":"Popovsky","year":"1985","journal-title":"Transfusion"},{"issue":"7","key":"R7-20261023","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/j.1537-2995.2012.03935.x","article-title":"The residual risk of transfusion-related acute lung injury at the American Red Cross (2008-2011): limitations of a predominantly male-donor plasma mitigation strategy","volume":"53","author":"Eder","year":"2013","journal-title":"Transfusion"},{"issue":"1","key":"R8-20261023","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/CCM.0000000000000675","article-title":"Male-predominant plasma transfusion strategy for preventing transfusion-related acute lung injury: a systematic review","volume":"43","author":"Schmickl","year":"2015","journal-title":"Crit Care Med"},{"key":"R9-20261023","doi-asserted-by":"crossref","DOI":"10.1111\/trf.18336","article-title":"Supplemental findings of the 2023 National Blood Collection and Utilization Survey","author":"Griffin","year":"2025","journal-title":"Transfusion."},{"key":"R10-20261023","article-title":"Have we reached a new baseline for blood collection and transfusion in the United States? National Blood Collection and Utilization Survey, 2023","author":"McDavid","year":"2025","journal-title":"Transfusion"},{"issue":"9","key":"R11-20261023","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/trf.13644","article-title":"Declining blood collection and utilization in the United States","volume":"56","author":"Chung","year":"2016","journal-title":"Transfusion"},{"issue":"9","key":"R12-20261023","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1111\/trf.15415","article-title":"Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population-based study","volume":"59","author":"Patel","year":"2019","journal-title":"Transfusion"},{"issue":"5","key":"R13-20261023","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2105\/AJPH.2021.306157","article-title":"Public policy impact of the COVID-19 pandemic on blood supply in the United States","volume":"111","author":"Riley","year":"2021","journal-title":"Am J Public Health"},{"issue":"2","key":"R15-20261023","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.surg.2006.02.014","article-title":"17\u03b2-estradiol administration following trauma-hemorrhage prevents the increase in Kupffer cell cytokine production and MAPK activation predominately via estrogen receptor-\u03b1","volume":"140","author":"Suzuki","year":"2006","journal-title":"Surgery"},{"issue":"2","key":"R16-20261023","doi-asserted-by":"crossref","first-page":"e9421","DOI":"10.1371\/journal.pone.0009421","article-title":"Estrogen receptor hormone agonists limit trauma hemorrhage shock-induced gut and lung injury in rats","volume":"5","author":"Doucet","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"R17-20261023","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.TA.0000153938.77777.26","article-title":"Hypercoagulability is most prevalent early after injury and in female patients","volume":"58","author":"Schreiber","year":"2005","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"R18-20261023","first-page":"1","article-title":"Greenish discoloration of plasma: Is it really a matter of concern?","volume":"13","author":"Mani","year":"2019","journal-title":"Asian J Transfus Sci"},{"issue":"10","key":"R19-20261023","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4103\/0019-5049.191704","article-title":"Green colour donor plasma","volume":"60","author":"Raghuwanshi","year":"2016","journal-title":"Indian J Anaesth"},{"issue":"8","key":"R20-20261023","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1177\/00031348221096571","article-title":"Green plasma has a superior hemostatic profile compared with standard color plasma","volume":"88","author":"Kalkwarf","year":"2022","journal-title":"Am Surg"},{"key":"R21-20261023","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1111\/trf.70115","article-title":"An assessment of green plasma: the in vitro hemostatic superiority of a currently discarded blood product","volume":"66","author":"Redden","year":"2026","journal-title":"Transfusion"},{"issue":"2","key":"R22-20261023","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jss.2013.03.072","article-title":"Association of hemodilution and blood pressure in uncontrolled bleeding","volume":"184","author":"Pawelczyk","year":"2013","journal-title":"J Surg Res"},{"issue":"5","key":"R23-20261023","first-page":"1279","article-title":"Thromboelastography identifies sex-related differences in coagulation","volume":"91","author":"Gorton","year":"2000","journal-title":"Anesth Analg"},{"issue":"4","key":"R24-20261023","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1213\/ANE.0b013e3181d31e91","article-title":"In normal controls, both age and gender affect coagulability as measured by thrombelastography","volume":"110","author":"Roeloffzen","year":"2010","journal-title":"Anesth Analg"},{"issue":"2","key":"R25-20261023","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/TA.0000000000003822","article-title":"Estradiol provokes hypercoagulability and affects fibrin biology: a mechanistic exploration of sex dimorphisms in coagulation","volume":"94","author":"Coleman","year":"2023","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"R26-20261023","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jamcollsurg.2019.01.009","article-title":"Trauma resuscitation consideration: sex matters","volume":"228","author":"Coleman","year":"2019","journal-title":"J Am Coll Surg"},{"issue":"04","key":"R27-20261023","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-2007-1003291","article-title":"Ceruloplasmin serum level in post-menopausal women treated with oral estrogens administered at different times","volume":"24","author":"Clemente","year":"1992","journal-title":"Horm Metab Res"},{"issue":"7568","key":"R28-20261023","first-page":"596","article-title":"Caeruloplasmin and green plasma: in women taking oral contraceptives, in pregnant women, and in patients with rheumatoid arthritis","volume":"292","author":"Tovey","year":"1968","journal-title":"Lancet"},{"issue":"6","key":"R29-20261023","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.contraception.2012.05.017","article-title":"Types of combined oral contraceptives used by US women","volume":"86","author":"Hall","year":"2012","journal-title":"Contraception"},{"issue":"4","key":"R30-20261023","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/ALN.0b013e3181672668","article-title":"Green plasma-revisited","volume":"108","author":"Elkassabany","year":"2008","journal-title":"Anesthesiology"},{"issue":"9","key":"R32-20261023","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.3390\/ijms23095090","article-title":"Engineering CRISPR\/Cas9 for multiplexed recombinant coagulation factor production","volume":"23","author":"Feser","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"10","key":"R33-20261023","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.3390\/ijms24108468","article-title":"Engineering human cells expressing CRISPR\/Cas9-synergistic activation mediators for recombinant protein production","volume":"24","author":"Feser","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"R34-20261023","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/09537104.2020.1719056","article-title":"Mouse models of hemostasis","volume":"31","author":"Mohammed","year":"2020","journal-title":"Platelets"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TA.0000000000005071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:01:15Z","timestamp":1792785675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TA.0000000000005071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000005071","relation":{},"ISSN":["2163-0755","2163-0763"],"issn-type":[{"value":"2163-0755","type":"print"},{"value":"2163-0763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"2026-01-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}